Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Allergan and MAP Pharmaceuticals Announce Collaboration on LEVADEX(TM) Investigational Therapy for Acute Migraine
Allergan and MAP Pharmaceuticals Announce Collaboration on LEVADEX(TM) Investigational Therapy for Acute Migraine
Allergan and MAP Pharmaceuticals Announce Collaboration on LEVADEX(TM) Investigational Therapy for Acute Migraine
Submitted by
admin
on January 31, 2011 - 8:39am
Source:
Trading Markets
News Tags:
Allergan
MAP Pharmaceuticals
Levadex
migraines
Headline:
Allergan and MAP Pharmaceuticals Announce Collaboration on LEVADEX(TM) Investigational Therapy for Acute Migraine
Do Not Allow Advertisers to Use My Personal information
